1. Home
  2. DOCN vs VTRS Comparison

DOCN vs VTRS Comparison

Compare DOCN & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DigitalOcean Holdings Inc.

DOCN

DigitalOcean Holdings Inc.

HOLD

Current Price

$167.23

Market Cap

16.3B

Sector

Technology

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$15.95

Market Cap

17.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOCN
VTRS
Founded
2011
1961
Country
United States
United States
Employees
N/A
30000
Industry
Retail: Computer Software & Peripheral Equipment
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.3B
17.7B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
DOCN
VTRS
Price
$167.23
$15.95
Analyst Decision
Buy
Buy
Analyst Count
14
4
Target Price
$85.46
$13.50
AVG Volume (30 Days)
2.9M
10.4M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
3.21%
EPS Growth
183.15
N/A
EPS
0.15
0.15
Revenue
$901,427,000.00
$14,299,900,000.00
Revenue This Year
$23.80
$4.41
Revenue Next Year
$30.11
$1.96
P/E Ratio
$1,205.73
$106.10
Revenue Growth
15.48
N/A
52 Week Low
$25.56
$8.63
52 Week High
$184.46
$17.53

Technical Indicators

Market Signals
Indicator
DOCN
VTRS
Relative Strength Index (RSI) 59.28 50.68
Support Level $40.96 $12.90
Resistance Level $164.69 $16.38
Average True Range (ATR) 12.63 0.34
MACD -0.89 -0.16
Stochastic Oscillator 55.01 34.13

Price Performance

Historical Comparison
DOCN
VTRS

About DOCN DigitalOcean Holdings Inc.

DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: